Cleared Traditional

Volumetric Infusion Controller (K153760) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K153760 · DEKA Research & Development · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2016
Decision
278d
Days
Class 2
Risk

K153760 is an FDA 510(k) clearance for the Volumetric Infusion Controller. Classified as Controller, Infusion, Intravascular, Electronic (product code LDR), Class II - Special Controls.

Submitted by DEKA Research & Development (Manchester, US). The FDA issued a Cleared decision on October 3, 2016 after a review of 278 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5725 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all DEKA Research & Development devices

Submission Details

510(k) Number K153760 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 30, 2015
Decision Date October 03, 2016
Days to Decision 278 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
149d slower than avg
Panel avg: 129d · This submission: 278d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LDR Controller, Infusion, Intravascular, Electronic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5725
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LDR Controller, Infusion, Intravascular, Electronic

All 59
Devices cleared under the same product code (LDR) and FDA review panel - the closest regulatory comparables to K153760.
DEKA Infusion System, DEKA Administration Set
K242693 · Deka Research and Development Corporation · Oct 2024
DEKA Infusion System, DEKA Administration Set
K232316 · Deka Research and Development · Mar 2024
3M IV FLOW REGULATOR
K896907 · 3M Company · Feb 1990
LIFECARE 75 CONTROLLER
K893487 · Abbott Laboratories · Jul 1989
ABBOTT LIFECARE 1050 CONTROLLER
K842080 · Abbott Laboratories · Jul 1984
LIFECARE 1000 CONTROLLER
K812114 · Abbott Laboratories · Aug 1981